Hemagen Diag Inc (HMGN) 0.0110 $HMGN Global Aph
Post# of 273249
Posted On: 09/27/2016 11:12:26 AM
Hemagen Diag Inc (HMGN) 0.0110 $HMGN
Global Apheresis Equipment Market 2015-2019 - High Demand for Plasma in Biopharmaceutical Companies
M2 - Wed Oct 21, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mdwp64/global_apheresis) has announced the addition of the "Global Apheresis Equipment Market 2015-2019" report to their offering. The global apheresis equipment market to grow at a CAGR of 10.72% over the period 2014-2019. This report covers the present scenario and the growth prospects of the global apheresis equipment market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various devices and disposables used in apheresis that are available in the market. The two major technologies discussed in the report are centrifugation and membrane filtration. The report includes a discussion of the key vendors operating in this market. National blood banks, hospitals, and non-profit organizations are undergoing collaborations to boost their operational efficiency. For instance, member physicians of the Blood Services Group organize regular meetings and seminars for clinicians of various hospitals. An efficient national blood system requires collaboration and coordination among government ministries, laboratories, blood banks, institutions for public health, non-profit organizations, and hospitals. According to the report, the incidence of hematological disorders, such as severe leukemia, anemia, and sickle cell disease, has increased worldwide over the past few years. Physicians use apheresis to collect plasma, platelets, white blood cells, red blood cells, and other blood components for treating hematological disorders. Further, the report states that the World Apheresis Association reported that the frequency of adverse reactions due to apheresis is less than those caused by the whole blood process. However, an adverse reaction due to apheresis is more likely to require hospitalization. Hypocalcemia is the most common complication of apheresis caused by citrate anticoagulation. This complication can cause hypoparathyroidism, acute pancreatitis, vitamin D deficiency, and chronic kidney diseases. Key vendors - Asahi Kasei Medical - Fenwal - Haemonetics - Macopharma - Terumo BCT Other prominent vendors - Cerus - Grifols - HemaCare - Hemagen Diagnostics - Immucor - Kawasumi Laboratories - Therakos For more information visit http://www.researchandmarkets.com/research/md..._apheresis
HAE: 36.76 (-0.26)
Global Apheresis Equipment Market 2015-2019 - High Demand for Plasma in Biopharmaceutical Companies
M2 - Wed Oct 21, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mdwp64/global_apheresis) has announced the addition of the "Global Apheresis Equipment Market 2015-2019" report to their offering. The global apheresis equipment market to grow at a CAGR of 10.72% over the period 2014-2019. This report covers the present scenario and the growth prospects of the global apheresis equipment market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various devices and disposables used in apheresis that are available in the market. The two major technologies discussed in the report are centrifugation and membrane filtration. The report includes a discussion of the key vendors operating in this market. National blood banks, hospitals, and non-profit organizations are undergoing collaborations to boost their operational efficiency. For instance, member physicians of the Blood Services Group organize regular meetings and seminars for clinicians of various hospitals. An efficient national blood system requires collaboration and coordination among government ministries, laboratories, blood banks, institutions for public health, non-profit organizations, and hospitals. According to the report, the incidence of hematological disorders, such as severe leukemia, anemia, and sickle cell disease, has increased worldwide over the past few years. Physicians use apheresis to collect plasma, platelets, white blood cells, red blood cells, and other blood components for treating hematological disorders. Further, the report states that the World Apheresis Association reported that the frequency of adverse reactions due to apheresis is less than those caused by the whole blood process. However, an adverse reaction due to apheresis is more likely to require hospitalization. Hypocalcemia is the most common complication of apheresis caused by citrate anticoagulation. This complication can cause hypoparathyroidism, acute pancreatitis, vitamin D deficiency, and chronic kidney diseases. Key vendors - Asahi Kasei Medical - Fenwal - Haemonetics - Macopharma - Terumo BCT Other prominent vendors - Cerus - Grifols - HemaCare - Hemagen Diagnostics - Immucor - Kawasumi Laboratories - Therakos For more information visit http://www.researchandmarkets.com/research/md..._apheresis
HAE: 36.76 (-0.26)
(0)
(0)Scroll down for more posts ▼